Passa al contenuto
Merck

Crystal Structure of Ripk4 Reveals Dimerization-Dependent Kinase Activity.

Structure (London, England : 1993) (2018-05-01)
Christine S Huang, Nina Oberbeck, Yi-Chun Hsiao, Peter Liu, Adam R Johnson, Vishva M Dixit, Sarah G Hymowitz
ABSTRACT

Receptor-interacting protein kinase 4 (RIPK4) is a highly conserved regulator of epidermal differentiation. Members of the RIPK family possess a common kinase domain as well as unique accessory domains that likely dictate subcellular localization and substrate preferences. Mutations in human RIPK4 manifest as Bartsocas-Papas syndrome (BPS), a genetic disorder characterized by severe craniofacial and limb abnormalities. We describe the structure of the murine Ripk4 (MmRipk4) kinase domain, in ATP- and inhibitor-bound forms. The crystallographic dimer of MmRipk4 is similar to those of RIPK2 and BRAF, and we show that the intact dimeric entity is required for MmRipk4 catalytic activity through a series of engineered mutations and cell-based assays. We also assess the impact of BPS mutations on protein structure and activity to elucidate the molecular origins of the disease.

MATERIALI
N° Catalogo
Marchio
Descrizione del prodotto

Millipore
Gel d′affinità ANTI-FLAG® M2, purified immunoglobulin, buffered aqueous glycerol solution
Sigma-Aldrich
Anticorpo monoclonale ANTI-FLAG® M2-perossidasi (HRP), clone M2, purified immunoglobulin, buffered aqueous glycerol solution
Sigma-Aldrich
CEP-701 hydrate, ≥98% (HPLC)